Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CRXT

Clarus Therapeutics (CRXT)

Clarus Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRXT
DateTimeSourceHeadlineSymbolCompany
03/07/20235:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRXTClarus Therapeutics Holdings Inc
03/01/20236:36AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CRXTClarus Therapeutics Holdings Inc
03/01/20236:23AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CRXTClarus Therapeutics Holdings Inc
03/01/20236:20AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
03/01/20236:17AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
03/01/20236:07AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
02/22/20233:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/24/20233:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
12/22/20223:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
11/23/20225:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
10/18/20223:05PMGlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful BidderNASDAQ:CRXTClarus Therapeutics Holdings Inc
09/14/20228:52AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CRXTClarus Therapeutics Holdings Inc
09/05/20229:19PMGlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy CodeNASDAQ:CRXTClarus Therapeutics Holdings Inc
08/26/20223:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/26/20223:33PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/26/20223:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/26/20223:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/22/202211:05AMTipRanksClarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at NeedhamNASDAQ:CRXTClarus Therapeutics Holdings Inc
08/19/20225:38AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/19/20225:34AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/19/20225:32AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/19/20225:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/18/20223:50PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/18/20223:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/18/20223:05PMGlobeNewswire Inc.Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce ReductionNASDAQ:CRXTClarus Therapeutics Holdings Inc
08/10/20225:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/10/20225:05AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
08/09/20224:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
07/28/20228:05AMGlobeNewswire Inc.Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)NASDAQ:CRXTClarus Therapeutics Holdings Inc
07/06/20223:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRXTClarus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRXT